Low Nirmatrelvir/Ritonavir Use Among Patients With Rheumatoid Arthritis: A Signal of Concern.

Authors :: Kwok TSH
Kuriya B
Eder L
Aghanya V
Gatley JM
Widdifield J
Source :: The Journal of rheumatology [J Rheumatol] 2023 Oct 01. Date of Electronic Publication: 2023 Oct 01.
Publication Year :: 2023
Publisher :: Ahead of Print
Abstract: Individuals with rheumatoid arthritis (RA) may be at increased risk of severe coronavirus disease 2019 (COVID-19) outcomes. <superscript>1</superscript> Nirmatrelvir/ritonavir has been shown to reduce the risk for hospitalization and death among patients with COVID-19 at risk for progression to severe disease. <superscript>2</superscript> .

Full Text Access

Tools